The Uromigos
Podcast autorstwa The Uromigos
401 Odcinki
-
Episode 383: A Neoantigen Vaccine Generates Anti-tumor Immunity in RCC
Opublikowany: 5.02.2025 -
Episode 382: Uromigos Japan - TROPICs-04の考察
Opublikowany: 5.02.2025 -
Episode 381: Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
Opublikowany: 27.01.2025 -
Episode 380: The Role of SBRT in RCC
Opublikowany: 13.01.2025 -
Episode 379: Uromigos Japan: 2024年のGU Oncologyを振り返る
Opublikowany: 10.01.2025 -
Episode 378: 2025 Preview of Important GU Data
Opublikowany: 6.01.2025 -
Episode 377: Prostate Cancer 2024 Highlights
Opublikowany: 23.12.2024 -
Episode 376: Bladder Cancer 2024 Highlights
Opublikowany: 23.12.2024 -
Episode 375: Renal Cancer 2024 Highlights
Opublikowany: 23.12.2024 -
Episode 374: Mechanisms of HIF Resistance
Opublikowany: 18.12.2024 -
Episode 373: KEYNOTE-564 Asian OSとANNARの解説
Opublikowany: 11.12.2024 -
Episode 372: FDA Accelerated Approval Process
Opublikowany: 9.12.2024 -
Episode 371: TROPICS-04 Results from ESMO Asia
Opublikowany: 7.12.2024 -
Episode 370: Artificial Intelligence in Medical Oncology
Opublikowany: 2.12.2024 -
Episode 369: Paper of the Month with Bishoy Faltas
Opublikowany: 25.11.2024 -
Episode 368: Radiomics in RCC: Live from IKCS
Opublikowany: 19.11.2024 -
Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in Prostate Cancer
Opublikowany: 11.11.2024 -
Episode 366: ARPIs in Prostate Cancer - Are They Different?
Opublikowany: 4.11.2024 -
Episode 365: A Review of the Advanced Prostate Cancer Consensus Conference (APCCC)
Opublikowany: 28.10.2024 -
Episode 364: 腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜
Opublikowany: 24.10.2024
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
